J Control Release. 2026 Nov 16:115551. doi: 10.1016/j.jconrel.2026.115551. Online ahead of print.
ABSTRACT
Dry eye disease (DED) is a prevalent ocular surface disorder that can progress to corneal epithelial damage and, in severe cases, vision loss. Effective management of DED is hampered by unfavorable physicochemical properties of both the ocular surface barrier and drug molecules. Resveratrol (RSV) exhibits antioxidant and anti-inflammatory activities but is limited by poor aqueous solubility and low ocular bioavailability. In this study, we formulated an RSV-loaded oil-in-water nanoemulsion eye drops (RSV-SF-NEs) with silk fibroin (SF) as a multifunctional core component. SF is a natural protein that serves simultaneously as an effective emulsifier to stabilize the nanoemulsion interface, a mucin-1 (MUC1)-targeted adhesion ligand to prolong corneal retention, and an intrinsic antioxidant to synergistically scavenge free radicals. SF’s multifunctionality enabled a 3-fold increase in ocular surface retention over free DiR and enhanced corneal epithelial uptake of RSV. In vitro, RSV-SF-NEs were internalized by corneal epithelial cells via macropinocytosis and protected cells from injury by inhibiting oxidative stress and restoring mitochondrial homeostasis. In a benzalkonium chloride-induced mouse dry eye model, RSV-SF-NEs reduced ocular surface inflammation and oxidative stress, accelerated corneal epithelial repair, and restored tear secretion. RSV-SF-NEs showed superior efficacy to cyclosporine A (CsA) eye drops and exhibited no obvious toxicity. Corneal proteomics revealed that RSV-SF-NEs exerted therapeutic effects by reversing dysregulated expression of mitochondrial proteins involved in oxidative phosphorylation and energy metabolism. This SF-centered “vector-function” strategy offers a promising therapeutic approach for DED.
PMID:43039322 | DOI:10.1016/j.jconrel.2026.115551